Earnings
📈 Stocks
MeiraGTx Targets December 2026 MAA Filing for Lead Gene Therapy Bota-vec
(just now)
MeiraGTx is advancing its clinical pipeline, with a pivotal Phase 2 data readout for radiation-induced xerostomia expected in mid-2027 and a cash…